[Does hypertension need treatment following correction of coarctation in childhood?]

P Ou1, E Mousseaux, I Szezepanski

  • 1Cardiologie pédiatrique, Université Paris V-Descartes, Necker-Enfants Malades. INSERM EMIU0016, 149, rue de Sèvres 75743 Paris 15.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|November 15, 2006
PubMed

Insights

Children treated for coarctation of the aorta (CoA) face lifelong hypertension (HT) risks. Early screening and potential interventions are crucial for managing this cardiovascular complication.

Area of Science:

  • Cardiology
  • Pediatric Surgery

Context:

  • Surgical repair of aortic coarctation (CoA) yields excellent outcomes.
  • Prenatal diagnosis improves outcomes, reducing preoperative mortality.
  • Despite surgical success, patients face a high risk of developing hypertension (HT) later in life.

Purpose:

  • To investigate the necessity of treating hypertension post-childhood coarctation repair.
  • To identify risk factors and screening objectives for long-term follow-up.
  • To explore new contributors to hypertension, including aortic arch geometry and arterial wall properties.

Summary:

  • Half of adolescents and two-thirds of 30-year-olds who underwent CoA repair develop hypertension.
  • Hypertension significantly increases mortality, primarily due to cardiovascular events.
  • Residual anomalies like recoarctation or aortic hypoplasia may require further intervention.

Impact:

  • Highlights the persistent risk of hypertension after childhood coarctation repair.
  • Emphasizes the importance of ongoing screening and management of hypertension.
  • Suggests potential for improved surgical techniques to optimize aortic arch geometry and prevent hypertension.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...